|
|
|
|
Lack of Clinically Relevant Drug Interactions Between
Elvitegravir plus Ritonavir Boosted-Atazanavir and Telaprevir
|
|
|
Reported by Jules Levin
20th International AIDS Conference, July 20-25, 2014, Melbourne
JM Custodio, S Guo, EB Lawson, H Cao, A Silva, BP Kearney, and S Ramanathan
Gilead Sciences, Inc., Foster City, CA, USA
|
|
|
|
|
|
|